| Serial Number | 98412212 |
| Word Mark | NOVALIQ |
| Filing Date | Tuesday, February 20, 2024 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, January 14, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, January 14, 2025 |
| Description of Mark | The mark consists of the wording "NOVALIQ" displayed in stylized characters in blue color. |
| Goods and Services | Anti-infectives; veterinary pharmaceutical preparations for treatment of ophthalmic disease; pharmaceutical preparations for ophthalmic use; medicinal preparations and pharmaceutical substances for ophthalmic use; liquid and semisolid pharmaceutical compositions for the treatment of eye diseases; eye drops; pharmaceutical preparations for the treatment of the dry eye disease; pharmaceutical preparations for the treatment of ocular surface diseases; pharmaceutical preparations for use in dermatology; medicated preparations for skin treatment; antimicrobials for dermatologic use; anti-dermoinfectives; pharmaceutical preparations for dental use; pharmaceutical preparations for the treatment of posterior eye diseases; pharmaceutical preparations for topical use for treating dermatologic conditions; pharmaceutical water-free preparations (exclusive medicaments, medicines), namely aids in the nature of veterinary pharmaceutical preparations for topical treatment of eye diseases and disorders and active substances comprising semifluorinated alkanes (SFAs) being medical aids. |
| Indication of Colors claimed | The color(s) blue is/are claimed as a feature of the mark. |
| Goods and Services | Medical and pharmacological research services; scientific research for medical purposes; chemical research and analysis services; scientific laboratory services; development of pharmaceutical preparations and medicines; scientific and technological consultancy relating to the syntheses and production of pharmaceuticals; clinical research in the fields of ophthalmic pharmaceutical preparations, dermatologic pharmaceutical preparations, semifluorinated alkanes (SFAs) and of topical medical treatments; testing, authentication and quality control for others in the field of semifluorinated alkanes (SFAs) and of water-free pharmaceutical preparations. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, February 20, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, February 20, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Novaliq GmbH |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Heidelberg 69120 DE |
| Party Name | Novaliq GmbH |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Heidelberg 69120 DE |
| Event Date | Event Description |
| Tuesday, February 20, 2024 | NEW APPLICATION ENTERED |
| Friday, February 23, 2024 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Tuesday, June 25, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, September 19, 2024 | NON-FINAL ACTION E-MAILED |
| Thursday, September 19, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, September 19, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, December 18, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, December 18, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, December 18, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, December 19, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, January 8, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, January 14, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, January 14, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 10, 2024 | ASSIGNED TO EXAMINER |